Join
Live feed
·
PRReleasevia Quantisnow
Royalty Pharma plc logo
Theravance Biopharma Inc. logo

Theravance Biopharma, Inc. Reports Second Quarter 2022 Financial Results and Provides Business Update

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track RPRX (Royalty Pharma plc), TBPH (Theravance Biopharma Inc.) and more on Quantisnow.